Anthony Joseph Perri Iii, MD Dermatology Medicare: Accepting Medicare Assignments Practice Location: 4015 Interstate 45 N Ste 200, Conroe, TX 77304 Phone: 936-522-4966 Fax: 936-522-4998 |
Dr. Bobbak Mansouri, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 508 Medical Center Blvd Ste 380, Conroe, TX 77304 Phone: 281-573-8333 |
Kristin Rose Wolf, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 508 Medical Center Blvd Ste 380, Conroe, TX 77304 Phone: 281-573-8333 Fax: 936-703-5323 |
Kemunto Mokaya, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 508 Medical Center Blvd Ste 380, Conroe, TX 77304 Phone: 281-573-8333 Fax: 936-703-5323 |
Greg Krenek, M.D. Dermatology Medicare: Accepting Medicare Assignments Practice Location: 503 Medical Center Blvd, Suite 140, Conroe, TX 77304 Phone: 936-756-0668 Fax: 936-756-7787 |
Anita Arora Gill, M.D. Dermatology Medicare: Not Enrolled in Medicare Practice Location: 1501 River Pointe Dr, Suite 140, Conroe, TX 77304 Phone: 936-760-3373 Fax: 936-760-3374 |
News Archive
Negative-pressure wound therapy probably does not promote healing. This is the conclusion of Frank Peinemann and Stefan Sauerland's meta-analysis in the current edition of Deutsches Ärzteblatt International.
While two advanced radiosurgery approaches — Gamma Knife and RapidArc — offer different strengths, they are equally effective at eradicating cancer in the brain, say researchers at Sidney Kimmel Cancer Center.
GE and Intel Corporation have announced the entry into a definitive agreement to form a 50/50 joint venture to create a new healthcare company focused on telehealth and independent living. The new company will be formed by combining assets of GE Healthcare's Home Health division and Intel's Digital Health Group, and will be owned equally by GE and Intel. Pending regulatory and other customary closing conditions, the joint venture is expected to become operational by the end of the year. Financial terms were not disclosed.
The majority of drugs used to treat asthma today are the same ones that were used 50 years ago. New drugs are urgently needed to treat this chronic respiratory disease, which causes nearly 25 million people in the United States alone to wheeze, cough, and find it difficult at best to take a deep breath.
There are now two reasons for patients to flinch at the touch of a stethoscope: because it's cold, of course; and because it's covered with germs.
› Verified 5 days ago